EMBLA — Embla Medical hf Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Embla Medical hf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	719	719	786	855	929
Cost of Revenue
Gross Profit	455	440	486	535	579
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	621	654	696	742	803
Operating Profit	97.3	64.8	89.4	113	125
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	86.6	56.2	76	90.6	108
Provision for Income Taxes
Net Income After Taxes	65.7	43.2	58.8	69	83.6
Minority Interest
Net Income Before Extraordinary Items
Net Income	64	42.5	58.4	68.3	83.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	64	42.5	58.4	68.3	83.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.152	0.102	0.139	0.16	0.195
Dividends per Share